SCHEMBL20678554

SCHEMBL20678554

CCC(C(=O)O)C1CCN(CCC=C2c3ccccc3Sc3ccccc32)CC1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 4/20 0.65
CYP3A4 P08684 5/20 0.49
CYP2D6 P10635 4/20 0.49
USP2 O75604 3/20 0.49
LMNA P02545 3/20 0.49
HTR1A P08908 3/20 0.49
ADRA2A P08913 3/20 0.49
DRD2 P14416 3/20 0.49
ADRA1A P35348 3/20 0.49
HRH1 P35367 3/20 0.49
DRD3 P35462 3/20 0.49
HTR6 P50406 3/20 0.49
SLC6A3 Q01959 3/20 0.49
KCNH2 Q12809 3/20 0.49
CYP1A2 P05177 3/20 0.49
CYP2C19 P33261 3/20 0.49
ADRA2B P18089 2/20 0.49
ADRA2C P18825 2/20 0.49
HTR2A P28223 2/20 0.49
HTR2C P28335 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19127667 0.82 SIGMAR1 (0.70) SIGMAR1CYP3A4CYP2D6USP2LMNA
SCHEMBL19153976 0.79 SIGMAR1 (0.65) SIGMAR1CYP3A4CYP2D6USP2LMNA
SCHEMBL7603081 0.78 SIGMAR1 (0.64) SIGMAR1CYP3A4CYP2D6USP2LMNA
Acetic Acid SCHEMBL8172274 0.78 SIGMAR1 (0.64) SIGMAR1CYP3A4CYP2D6USP2LMNA
SCHEMBL7605940 0.76 SIGMAR1 (0.60) SIGMAR1CYP3A4CYP2D6USP2LMNA
SCHEMBL8181729 0.76 SIGMAR1 (0.60) SIGMAR1CYP3A4CYP2D6USP2LMNA
SCHEMBL19126835 0.74 CYP3A4 (0.80) SIGMAR1CYP3A4CYP2D6USP2LMNA
SCHEMBL8176002 0.74 CHRM1 (0.47) SIGMAR1ADRA1AHRH1HTR2ACHRM1
SCHEMBL7604550 0.74 SLC6A1 (0.58) SIGMAR1CYP2D6LMNACYP1A2CYP2C19
SCHEMBL8172276 0.73 SIGMAR1 (0.60) SIGMAR1CYP3A4CYP2D6USP2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10766873-B2 Zuclopenthixol hydrochloride derivatives and Ebselen derivatives as ErbB2 inhibitors CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) 2020-09-08 US disclosed
US-20190031639-A1 ZUCLOPENTHIXOL HYDROCHLORIDE DERIVATIVES AND EBSELEN DERIVATIVES AS ERBB2 INHIBITORS CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) 2019-01-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190031639-A1 ZUCLOPENTHIXOL HYDROCHLORIDE DERIVATIVES AND EBSELEN DERIVATIVES AS ERBB2 INHIBITORS ERBB2, ERBB3, EGFR SIGMAR1 3662/4885CYP3A4 3407/4885CYP2D6 2315/4885
US-10766873-B2 Zuclopenthixol hydrochloride derivatives and Ebselen derivatives as ErbB2 inhibitors ERBB2, ERBB3, EGFR SIGMAR1 3662/4885CYP3A4 3407/4885CYP2D6 2315/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.